The objective response rate (ORR) of mucosal melanoma to anti‐PD‐1/PD‐L1 monotherapy was 0%–23.3%,11, 12, 13 which was inferior to that of cutaneous melanoma (33.7%–43.7%).14, 15. The gene discussed is CD274; the disease is cutaneous melanoma.